Hyderabad, Oct 9 (Maxim News) Reinforcing its title as the vaccine capital of India, a major pharma company from Hyderabad is set to re-energise the global supply of the life-saving oral cholera vaccine.
Shanchol, the oral cholera vaccine originally developed by Hyderabad-based Shantha Biotechnics, has received prequalification from the World Health Organization (WHO), enabling global procurement agencies such as UNICEF, Gavi and PAHO to source the vaccine for use in countries where cholera remains a major public health challenge, a statement here on Thursday said.
“Shanchol was conceived as an affordable and accessible solution for countries facing repeated cholera outbreaks. The WHO prequalification of the vaccine carries forward that founding mission,” said Dr K I Varaprasad Reddy, Founder of Shantha Biotechnics.
Over the years, close to 40 million doses of Shanchol have been supplied worldwide through UNICEF-led vaccination campaigns. After production was paused under its former ownership, GCBC Vaccines Pvt Ltd (formerly Shantha) resumed manufacturing, with WHO conducting an on-site inspection and transferring the prequalification.
Shanchol remains the only oral cholera vaccine manufactured in India with WHO prequalification, underscoring India’s key role in ensuring the continuity of global supply.
“As part of the founding family of Gland Pharma, I have seen how world-class sterile manufacturing from India can transform global healthcare. By resuming production of Shanchol, we are bringing the same rigour and reliability to ensure this life-saving vaccine remains available worldwide,” said Dr Ravi Penmetsa, Managing Director, GCBC Vaccines Pvt Ltd.
“This milestone underscores Shantha’s renewed commitment to global health. Our focus is on ensuring that vaccines like Shanchol reach the countries that need them most, reliably and affordably. At the same time, we are working to bring other affordable and innovative vaccines from our pipeline to global markets, continuing Shantha’s tradition of expanding access to life-saving immunisation,” said Dr Vishy Chebrol, Executive Director, GCBC Vaccines Pvt Ltd. (Maxim News)
Next Story:
iPhone 18 Pro Price May Cross ₹1.5 Lakh as Apple Eyes Major Upgrade
Hyderabad: Apple’s upcoming iPhone 18 Pro series is expected to become significantly more expensive, with reports suggesting the starting price could cross ₹1.5 lakh in India. The premium pricing is reportedly linked to major hardware upgrades, including Apple’s next-generation A20 chipset, improved cameras and increased memory.
KTR Appears Before Nampally Court in Formula E Case
Hyderabad: BRS Working President and former Telangana Minister K.T. Rama Rao (KTR) appeared before the Special Anti-Corruption Bureau (ACB) Court at Nampally on Friday in connection with the high-profile Formula E race case, complying with the summons issued by the court. The appearance marked the formal commencement of court proceedings after the ACB filed its charge sheet in the…
Anti Paper Leak Bill 2026: Modi Warns Paper Leak Gangs
Anti Paper Leak Bill 2026 | PM Narendra Modi said the Anti Paper Leak Bill 2026 will strengthen India’s exam system and warned of strict action against paper leak syndicates.
Gold Rates Today Sees A Rise In Hyderabad On 31 July
Gold Rates Today | Hyderabad, July 31: The gold rates today in Hyderabad sees a surge on 31 July, 2026.
Peddi Sudarshan Reddy Dies, Kavitha expresses grief
Peddi Sudarshan Reddy passed away at 52. Kalvakuntla Kavitha paid tribute and expressed condolences.
Now you can get the latest stories from Indtoday on Telegram every day. Click the link to subscribe. Click to follow Indtoday’s Facebook page, Twitter, and Instagram. For all the latest Hyderabad News updates
